Male urinary incontinence (MUI) is a common yet often underdiagnosed condition that significantly affects quality of life, emotional well-being, and daily activities. It is characterized by the involuntary leakage of urine and is frequently associated with aging, neurological disorders, prostate enlargement, or complications following prostate surgery. As awareness increases and treatment options continue to improve, healthcare providers are focusing on patient-centered solutions that combine advanced medical devices, minimally invasive therapies, and supportive continence products. The growing adult incontinence products market, expanding urinary incontinence devices segment, and increasing demand for prostate surgery incontinence treatment are driving the growth of the Male Urinary Incontinence Market.

The global male urinary incontinence market was valued at USD 7.59 billion in 2024 and is projected to grow at a CAGR of 6.3% from 2025 to 2034. The market is expected to reach USD 8.05 billion in 2025 and expand to USD 13.93 billion by 2034

Adult Incontinence Products Market Supporting Daily Patient Care

The expanding adult incontinence products market plays a vital role in improving comfort, independence, and quality of life for individuals experiencing urinary leakage. While definitive medical treatment remains the goal, absorbent products provide effective symptom management for many patients.

Common adult incontinence products include:

• Absorbent pads and guards
• Protective underwear
• Adult briefs
• Bed protectors
• Drip collectors
• Disposable and reusable continence products

Manufacturers continue to develop thinner, more discreet, and highly absorbent products that offer improved comfort and odor control. Modern materials enhance moisture management while reducing skin irritation, making these products more suitable for long-term daily use.

The increasing acceptance of continence care products and improved product availability through retail pharmacies, hospitals, and online platforms continue to support market growth. Homecare remains an important end-use segment as more patients manage urinary incontinence outside hospital settings.

Urinary Incontinence Devices Driving Clinical Innovation

The growing demand for urinary incontinence devices is transforming treatment options for male patients. These devices provide minimally invasive and surgical solutions designed to restore bladder control and improve long-term outcomes.

Common urinary incontinence devices include:

• Artificial urinary sphincters
• Male slings
• External compression devices
• Penile clamps
• Urinary catheters
• Drainage systems

Artificial urinary sphincters remain one of the most effective surgical options for men with moderate to severe stress urinary incontinence, particularly following prostate surgery. Male sling systems offer another minimally invasive solution by providing urethral support and reducing urine leakage.

Advancements in biomaterials, implant design, and minimally invasive surgical techniques continue to improve procedural success rates while reducing recovery times and postoperative complications.

Prostate Surgery Incontinence Treatment Expanding Therapeutic Options

The increasing need for prostate surgery incontinence treatment is a major contributor to the growth of the Male Urinary Incontinence Market. Urinary incontinence is one of the most common complications following radical prostatectomy and other prostate procedures performed for prostate cancer or benign prostatic hyperplasia (BPH).

Treatment strategies include:

• Pelvic floor muscle rehabilitation
• Behavioral therapy
• Medications
• Male sling procedures
• Artificial urinary sphincter implantation
• Lifestyle modifications

Early rehabilitation and individualized treatment plans can significantly improve continence recovery after surgery. Physicians increasingly combine conservative therapies with advanced surgical interventions to achieve optimal patient outcomes.

Growing awareness among patients and healthcare providers has encouraged earlier diagnosis and treatment, helping reduce the long-term physical and psychological burden associated with post-prostate surgery incontinence.

Key Growth Drivers of the Male Urinary Incontinence Market

Several important factors continue to accelerate the growth of the global Male Urinary Incontinence Market.

Growing aging population

The increasing number of elderly men worldwide is contributing to higher rates of urinary incontinence associated with age-related bladder dysfunction and chronic diseases.

Rising prostate disease prevalence

Increasing diagnoses of prostate cancer and benign prostatic hyperplasia are leading to a greater number of prostate surgeries, creating sustained demand for post-surgical continence management.

Technological advancements

Innovations in urinary incontinence devices, absorbent products, minimally invasive surgical techniques, and patient-centered treatment approaches continue to improve clinical outcomes.

Increasing awareness and diagnosis

Educational initiatives and improved physician awareness are encouraging more patients to seek treatment rather than viewing urinary incontinence as a normal part of aging. A recent survey also highlighted that stigma remains a barrier, emphasizing the need for greater awareness and discussion of available treatment options.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/male-urinary-incontinence-market

Key Players

• ABENA
• Attends Healthcare Products, Inc. (Domtar Corporation)
• BD
• Boston Scientific Corporation
• Cardinal Health
• Coloplast Corp.
• Essity
• First Quality
• Hollister Incorporated
• Kimberly-Clark Worldwide Inc.
• Medline
• Ontex Healthcare
• PAUL HARTMANN AG
• Teleflex Incorporated

Market Challenges

Despite favorable growth prospects, several challenges remain.

Many men continue to delay treatment because of embarrassment, social stigma, or the misconception that urinary incontinence is an unavoidable consequence of aging. Surgical procedures may not be appropriate for every patient, and advanced treatment options can be associated with higher costs.

Differences in reimbursement policies, access to specialized urology care, and patient education also influence treatment adoption across different regions.

Regional Analysis

North America currently dominates the Male Urinary Incontinence Market due to advanced healthcare infrastructure, high awareness levels, widespread availability of innovative continence products, and strong adoption of minimally invasive urological procedures.

Europe represents another major regional market, supported by an aging population, established healthcare systems, and increasing investment in urological care.

Asia Pacific is expected to witness the fastest growth during the forecast period. Rising healthcare expenditure, increasing awareness of men's health, expanding access to specialized urology services, and improving availability of continence care products are creating significant growth opportunities across China, India, Japan, and other emerging economies.

Future Outlook

The future of the Male Urinary Incontinence Market will be driven by continued expansion of the adult incontinence products market, technological innovation in urinary incontinence devices, and increasing demand for prostate surgery incontinence treatment. Emerging technologies such as smart continence monitoring systems, advanced implantable devices, regenerative therapies, and digital pelvic floor rehabilitation programs are expected to further improve patient outcomes.

More Trending Latest Reports By Polaris Market Research:

Ultrasound Devices Market

Electrophysiology Devices Market

Europe Induced Pluripotent Stem Cell (iPSC) Market

U.S. Microarray Market

Orthobiologics Market

Lateral Flow Assay Market

Lifestyle Diseases Apps Market

Patient Temperature Management Market